Oncology & Cancer

A new tool to confront lung cancer

Only 15% of patients with squamous cell lung cancer – the second most common lung cancer – survive five years past diagnosis. Little is understood about how the deadly disease arises, preventing development of targeted ...

Oncology & Cancer

Clinical trial delivers good results in leukemia patients

Huntsman Cancer Institute (HCI) researchers Michael Deininger, M.D., Ph.D., and Thomas O'Hare, Ph.D., were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard ...

Alzheimer's disease & dementia

Study contradicts belief that cancer protects against Alzheimer's

Despite studies that claim people with cancer are less likely to develop Alzheimer's disease—raising the possibility that what triggers cancer also prevents the neurodegenerative disorder—a new investigation finds a more ...